Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New PDE4 inhibitors prepared and tested at Mercian

Sep. 10, 2002

Potential new treatments for chronic bronchitis targeting 15-LO sought by Pfizer

Sep. 10, 2002

Syk inhibitors synthesized at Novartis as novel therapeutics for asthma

Sep. 10, 2002

Orally active B-cell IgE synthesis inhibitors discovered by Novartis team

Sep. 10, 2002

New bronchodilators prepared and tested at Mercian

Sep. 9, 2002

Tachykinin antagonists and potential uses described in recent patent

Sep. 6, 2002

Actimmune shows survival benefit in phase III IPF trial

Sep. 6, 2002

Novel human neutrophil elastase inhibitor effective in animal models of acute organ injury

Sep. 5, 2002

SSR-69071 selected for development as an HLE inhibitor for respiratory diseases

Sep. 4, 2002

Long-acting bronchodilators emerge from research at Almirall Prodesfarma

Sep. 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...